• Markets
    • icon
  • Companies
FPH · ASX

Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)

AU$21.46

 -0.26 (-1.197%)
ASX:Live
05/12/2023 04:10:44 PM
Hammer Bearish HALO Small HALO Ords HALO Earnings Momentum HALO 200 +5
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

FPH Overview

FPH Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About FPH

Website

Fisher & Paykel Healthcare Corporation Limited

Telephone

64.9.574.0100

Address

East Tamaki 15 Maurice Paykel Place Auckland 2013

Description

Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.

FPH Price Chart

Key Stats

Market Cap

AU$12.90B

PE

57.90

EV/EBITDA

34.0

Dividends Overview

DIV Yield

1.6%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 18.58 - 26.08

Trade Value (12mth)

AU$2,546,188.00

1 week

-3.33%

1 month

6.55%

YTD

0.61%

1 year

-6.53%

All time high

34.92

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

585m

HALO Sector

Healthcare

Next Company Report Date

21-May-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.77

FPH Announcements

Latest Announcements

Date Announcements

31 March 08

Presentation to UBS Growth Conference, Auckland

×

Presentation to UBS Growth Conference, Auckland

31 July 12

FPH 2012 Notice of Annual Meeting and Proxy Form

×

FPH 2012 Notice of Annual Meeting and Proxy Form

31 July 12

FPH Notice of Annual Shareholders Meeting 2012

×

FPH Notice of Annual Shareholders Meeting 2012

31 July 12

FPH 2012 Annual Meeting Proxy Form

×

FPH 2012 Annual Meeting Proxy Form

30 October 23

Application for quotation of securities - FPH

×

Application for quotation of securities - FPH

30 October 23

Application for quotation of securities - FPH

×

Application for quotation of securities - FPH

30 October 23

Disclosure Document

×

Disclosure Document

30 November 15

FPH Presentation to Analysts and Fund Managers

×

FPH Presentation to Analysts and Fund Managers

30 May 22

Cather Simpson appointed to Fisher & Paykel Healthcare Board

×

Cather Simpson appointed to Fisher & Paykel Healthcare Board

30 May 22

FPH Announces New Future Director Appointment

×

FPH Announces New Future Director Appointment

30 March 23

Notification of cessation of securities - FPH

×

Notification of cessation of securities - FPH

30 March 23

Application for quotation of securities - FPH

×

Application for quotation of securities - FPH

30 August 22

Change of Director's Interest Notice

×

Change of Director's Interest Notice

30 August 22

Change of Director's Interest Notice

×

Change of Director's Interest Notice

29 September 23

Ongoing Disclosure Notices - Options & Ordinary Shares

×

Ongoing Disclosure Notices - Options & Ordinary Shares

29 November 23

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

29 November 23

Dividend/Distribution - FPH

×

Dividend/Distribution - FPH

29 November 22

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

29 November 22

Dividend/Distribution - FPH

×

Dividend/Distribution - FPH

29 November 22

Dividend Reinvestment Plan

×

Dividend Reinvestment Plan

29 May 06

FY06 Presentation to Analysts/Fund Managers

×

FY06 Presentation to Analysts/Fund Managers

29 June 10

Annual Report to shareholders

×

Annual Report to shareholders

29 June 07

Notice of Annual General Meeting

×

Notice of Annual General Meeting

29 June 07

Annual Report

×

Annual Report

29 August 23

FPH provides guidance for first half of FY24

×

FPH provides guidance for first half of FY24

29 August 23

2023 Annual Shareholders Meeting Speeches and Presentation

×

2023 Annual Shareholders Meeting Speeches and Presentation

29 August 23

2023 Annual Shareholders' Meeting Results

×

2023 Annual Shareholders' Meeting Results

FPH Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.85 0.62 N/A Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.85 0.61 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 79.3 -27.8 N/A Lock Lock Lock
     PE X Lock Lock Lock Lock 33.2 31.4 57.9 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 21.8 19.0 34.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 1.12 0.60 N/A Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.46 -0.06 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 92.9 -46.5 N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.6 -0.3 N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.42 0.44 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 35.8 4.9 N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.5 1.8 1.6 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 49 71 N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock 2.43 2.70 N/A Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 2.30 2.56 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 51.5 11.2 N/A Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 579 580 N/A Lock Lock Lock
Basic m Lock Lock Lock Lock 574 577 N/A Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 1,819 1,548 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 50.4 -14.9 N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 498 516 N/A Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 1,142 955 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 42.1 -16.3 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 62.8 61.7 N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 37 38 N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 723 530 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 69.1 -26.7 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 39.7 34.2 N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 79 90 N/A Lock Lock Lock
EBIT $m Lock Lock Lock Lock 644 440 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 74.1 -31.7 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 35.4 28.4 N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 671 475 N/A Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 181 120 N/A Lock Lock Lock
Net Income $m Lock Lock Lock Lock 489 355 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 79.3 -27.4 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 26.9 22.9 N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 584 306 N/A Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 172 160 N/A Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -362 -84 N/A Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -176 -222 N/A Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 434 175 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 159.6 -59.7 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.1 N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 347 269 N/A Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 1,908 1,952 N/A Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 84 81 N/A Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -238 -172 N/A Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 510 396 N/A Lock Lock Lock
Equity $m Lock Lock Lock Lock 1,398 1,556 N/A Lock Lock Lock
Invested Capital Lock Lock Lock Lock 1,483 1,637 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 50.4 10.4 N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 25.7 18.2 N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 35.0 22.8 N/A Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 49.8 27.8 N/A Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 39.7 22.8 N/A Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 47.3 19.6 N/A Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 154.9 114.8 N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.3 -0.3 N/A Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -17.0 -11.0 N/A Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.2 2.9 N/A Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.5 1.7 N/A Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 41.0 32.7 N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 148.5 108.6 N/A Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 8.5 8.2 N/A Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 3.5 2.0 N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 4.0 2.9 N/A Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 2.9 3.2 N/A Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.0 0.8 N/A Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.0 0.8 N/A Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 36.9 30.7 N/A Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 35.1 24.4 N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 27.0 25.2 N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 25.7 18.2 N/A Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.3 N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 35.0 22.8 N/A Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 51.0 28.9 N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 17.9 6.6 N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 105.2 178.9 N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 42.8 44.8 N/A Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 148.1 223.7 N/A Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 27.7 27.5 N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 120.3 196.2 N/A Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

1.6%

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.77%

Value ($M)

93

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

0.20%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

FPH Shortsell

Frequently Asked Questions

The current share price of Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is AU$21.46.
The 52-week high share price for Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is AU$26.08.
The 52-week low share price for Fisher & Paykel Healthcare Corporation Limited (FPH:ASX)? is AU$18.58.
The current TTM dividend payout for Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is 1.60.
The last dividend payment of Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is AU$0.25.
Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) has a franking level of 0%.
Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is classified in the Healthcare.
The current P/E ratio for Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is 57.90.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.